Aqel S, Ahmad J, Saleh I, Fathima A, Al Thani A, Mohamed W
Biology (Basel). 2025; 14(2).
PMID: 40001897
PMC: 11852324.
DOI: 10.3390/biology14020129.
Simmons D, Selvaraj S, Chen T, Cao G, Camelo T, McHugh T
Mol Ther Methods Clin Dev. 2025; 33(1):101415.
PMID: 39995448
PMC: 11848452.
DOI: 10.1016/j.omtm.2025.101415.
Choquet D, Opazo P, Zhang H
Transl Neurodegener. 2025; 14(1):8.
PMID: 39934896
PMC: 11817889.
DOI: 10.1186/s40035-025-00470-z.
Scordino M, Stepanova P, Srinivasan V, Pham D, Eriksson O, Lalowski M
Front Mol Neurosci. 2024; 17:1473058.
PMID: 39359687
PMC: 11446244.
DOI: 10.3389/fnmol.2024.1473058.
Nateghi B, Keraudren R, Boulay G, Bazin M, Goupil C, Canet G
Front Neurosci. 2024; 18:1421680.
PMID: 39170678
PMC: 11337869.
DOI: 10.3389/fnins.2024.1421680.
Neuroprotection by ADAM10 inhibition requires TrkB signaling in the Huntington's disease hippocampus.
Scolz A, Vezzoli E, Villa M, Talpo F, Cazzola J, Raffin F
Cell Mol Life Sci. 2024; 81(1):333.
PMID: 39112663
PMC: 11335257.
DOI: 10.1007/s00018-024-05382-1.
Multi-omic analysis of Huntington's disease reveals a compensatory astrocyte state.
Paryani F, Kwon J, Ng C, Jakubiak K, Madden N, Ofori K
Nat Commun. 2024; 15(1):6742.
PMID: 39112488
PMC: 11306246.
DOI: 10.1038/s41467-024-50626-0.
Mitochondrial targeted antioxidants as potential therapy for huntington's disease.
Upadhayay S, Kumar P
Pharmacol Rep. 2024; 76(4):693-713.
PMID: 38982016
DOI: 10.1007/s43440-024-00619-z.
Neurotrophin-3 Rescues Striatal Synaptic Plasticity in Model of Neurodegeneration by PLC Signaling Activation.
Gomez-Pineda V, Nieto-Mendoza E, Torres-Cruz F, Hernandez-Echeagaray E
CNS Neurol Disord Drug Targets. 2024; 23(12):1488-1498.
PMID: 38859788
DOI: 10.2174/0118715273298919240531110022.
Brain-Derived Neurotrophic Factor, Nociception, and Pain.
Merighi A
Biomolecules. 2024; 14(5).
PMID: 38785946
PMC: 11118093.
DOI: 10.3390/biom14050539.
Construction of human 3D striato-nigral assembloids to recapitulate medium spiny neuronal projection defects in Huntington's disease.
Wu S, Hong Y, Chu C, Gan Y, Li X, Tao M
Proc Natl Acad Sci U S A. 2024; 121(22):e2316176121.
PMID: 38771878
PMC: 11145230.
DOI: 10.1073/pnas.2316176121.
Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington's disease.
Shafie A, Ashour A, Anwar S, Anjum F, Hassan M
Arch Pharm Res. 2024; 47(6):571-595.
PMID: 38764004
DOI: 10.1007/s12272-024-01499-w.
Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases.
Kampmann M
Nat Rev Neurosci. 2024; 25(5):351-371.
PMID: 38575768
DOI: 10.1038/s41583-024-00806-0.
Nebulization of low-dose aspirin ameliorates Huntington's pathology in N171-82Q transgenic mice.
Mondal S, Prieto S, Rangasamy S, Dutta D, Pahan K
NeuroImmune Pharm Ther. 2024; 3(1):47-59.
PMID: 38532785
PMC: 10961486.
DOI: 10.1515/nipt-2023-0026.
Neuropathogenesis-on-chips for neurodegenerative diseases.
Amartumur S, Nguyen H, Huynh T, Kim T, Woo R, Oh E
Nat Commun. 2024; 15(1):2219.
PMID: 38472255
PMC: 10933492.
DOI: 10.1038/s41467-024-46554-8.
Lowering mutant huntingtin by small molecules relieves Huntington's disease symptoms and progression.
Bahat A, Itzhaki E, Weiss B, Tolmasov M, Tsoory M, Kuperman Y
EMBO Mol Med. 2024; 16(3):523-546.
PMID: 38374466
PMC: 10940305.
DOI: 10.1038/s44321-023-00020-y.
Rapid and high-purity differentiation of human medium spiny neurons reveals LMNB1 hypofunction and subtype necessity in modeling Huntington's disease.
Wu J, Ren J, Cui H, Xie Y, Tang Y
Inflamm Regen. 2024; 44(1):7.
PMID: 38360694
PMC: 10870681.
DOI: 10.1186/s41232-024-00320-x.
Perinatal Tissue-Derived Stem Cells: An Emerging Therapeutic Strategy for Challenging Neurodegenerative Diseases.
Bruno A, Milillo C, Anaclerio F, Buccolini C, DellElice A, Angilletta I
Int J Mol Sci. 2024; 25(2).
PMID: 38256050
PMC: 10815412.
DOI: 10.3390/ijms25020976.
The role of sphingosine-1-phosphate in the development and progression of Parkinson's disease.
Wang W, Zhao Y, Zhu G
Front Cell Neurosci. 2024; 17:1288437.
PMID: 38179204
PMC: 10764561.
DOI: 10.3389/fncel.2023.1288437.
Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity.
Gan H, Cerbone M, Dattani M
Endocr Rev. 2023; 45(3):309-342.
PMID: 38019584
PMC: 11074800.
DOI: 10.1210/endrev/bnad033.